{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T06:28:36Z","timestamp":1776666516753,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006389","name":"University of Geneva","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Hospital-acquired bloodstream infections (HA-BSI), including catheter-associated bloodstream infections (CABSI), cause preventable harm in haemato-oncology patients but surveillance data are limited.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective cohort study using prospectively collected data in a large hospital network in Switzerland from 2017\u20132022. Incidence, source, and microbiology of HA-BSI were compared between (1) haematology patients with acute leukaemia or allogeneic stem cell transplantation (2) oncology patients with solid tumour or lymphoma, and (3) general medical patients. No routine quinolone prophylaxis was prescribed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We included 320,058 patient-days and 201,081 catheter-days across two haematology, two oncology and nine non-COVID-19 general medical wards. 669 HA-BSI occurred in 547 individual patients. In haematology patients, HA-BSI incidence was 9.1\/1000 patient-days (95% CI 8.2\u201310.3). 224\/299 (75%) of episodes were \u201cunknown\/other\u201d source. Low virulence Gram-positive organisms (coagulase-negative staphylococci, <jats:italic>viridans Streptococci<\/jats:italic>, enterococci) accounted for 232\/378 (61%) HA-BSI organisms and 46\/52 (88%) CABSI organisms. Compared to oncology and general medical patients, haematology patients had higher HA-BSI incidence, but a smaller proportion of infections caused by virulent organisms (Gram-negative bacteria, <jats:italic>Staphylococcus aureus<\/jats:italic>, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In haematology patients, HA-BSI are less commonly caused by virulent Gram-negative organisms or <jats:italic>Staphylococcus aureus<\/jats:italic> compared to solid tumour and general medical patients, in the absence of quinolone prophylaxis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s15010-025-02524-w","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T11:00:56Z","timestamp":1744196456000},"page":"1929-1939","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology of hospital-acquired bloodstream infections in haemato-oncology patients in Geneva, Switzerland"],"prefix":"10.1007","volume":"53","author":[{"given":"Aleece","family":"MacPhail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-No\u00eblle","family":"Chra\u00efti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aude","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaud","family":"Catho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Fortchantre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-C\u00e9line","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Camus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Masouridi-Levrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"McQuilten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Harbarth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niccol\u00f2","family":"Buetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"issue":"9","key":"2524_CR1","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1080\/0284186X.2017.1309063","volume":"56","author":"EC Haukland","year":"2017","unstructured":"Haukland EC, von Plessen C, Nieder C, Vonen B. Adverse events in hospitalised cancer patients: a comparison to a general hospital population. Acta Oncol. 2017;56(9):1218\u201323.","journal-title":"Acta Oncol"},{"key":"2524_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1592-1","volume":"16","author":"P Cornejo-Ju\u00e1rez","year":"2016","unstructured":"Cornejo-Ju\u00e1rez P, Vilar-Compte D, Garc\u00eda-Horton A, L\u00f3pez-Vel\u00e1zquez M, \u00d1amendys-Silva S, Volkow-Fern\u00e1ndez P. Hospital-acquired infections at an oncological intensive care cancer unit: differences between solid and hematological cancer patients. BMC Infect Dis. 2016;16:1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"8","key":"2524_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1086\/671281","volume":"34","author":"I See","year":"2013","unstructured":"See I, Iwamoto M, Allen-Bridson K, Horan T, Magill SS, Thompson ND. Mucosal barrier injury Laboratory-Confirmed bloodstream infection: results from a field test of a new National healthcare safety network definition. Infect Control Hosp Epidemiol. 2013;34(8):769\u201376.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"2524_CR4","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1093\/cid\/cir200","volume":"52","author":"TG Fraser","year":"2011","unstructured":"Fraser TG, Gordon SM. CLABSI rates in immunocompromised patients: A valuable patient centered outcome?? Clin Infect Dis. 2011;52(12):1446\u201350.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"2524_CR5","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1038\/s41409-019-0489-1","volume":"54","author":"CE Dandoy","year":"2019","unstructured":"Dandoy CE, Alonso PB. MBI-LCBI and CLABSI: more than scrubbing the line. Bone Marrow Transplant. 2019;54(12):1932\u20139.","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"2524_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.ajic.2016.03.011","volume":"44","author":"A-M Chaftari","year":"2016","unstructured":"Chaftari A-M, Jordan M, Hachem R, Al Hamal Z, Jiang Y, Yousif A, et al. A clinical practical approach to the surveillance definition of central line\u2013associated bloodstream infection in cancer patients with mucosal barrier injury. Am J Infect Control. 2016;44(8):931\u20134.","journal-title":"Am J Infect Control"},{"issue":"1","key":"2524_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1086\/668431","volume":"34","author":"JT Freeman","year":"2013","unstructured":"Freeman JT, Elinder-Camburn A, McClymont C, Anderson DJ, Bilkey M, Williamson DA, et al. Central Line\u2013Associated bloodstream infections in adult hematology patients with febrile neutropenia an evaluation of surveillance definitions using differential time to blood culture positivity. Infect Control Hosp Epidemiol. 2013;34(1):89\u201392.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"2524_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1469-0691.2012.03879.x","volume":"19","author":"C Gudiol","year":"2013","unstructured":"Gudiol C, Bodro M, Simonetti A, Tubau F, Gonz\u00e1lez-Barca E, Cisnal M, et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect. 2013;19(5):474\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"2524_CR9","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.cmi.2017.03.020","volume":"23","author":"M Weisser","year":"2017","unstructured":"Weisser M, Theilacker C, Sutter ST, Babikir R, Bertz H, G\u00f6tting T, et al. Secular trends of bloodstream infections during neutropenia in 15 181 Haematopoietic stem cell transplants: 13-year results from a European multicentre surveillance study (ONKO-KISS). Clin Microbiol Infect. 2017;23(11):854\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2524_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","volume":"76","author":"M Mikulska","year":"2018","unstructured":"Mikulska M, Averbuch D, Tissot F, Cordonnier C, Akova M, Calandra T, et al. Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines. J Infect. 2018;76(1):20\u201337.","journal-title":"J Infect"},{"issue":"1b","key":"2524_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1445-5994.2010.02341.x","volume":"41","author":"M Slavin","year":"2011","unstructured":"Slavin M, Lingaratnam S, Mileshkin L, Booth D, Cain M, Ritchie DS, et al. Use of antibacterial prophylaxis for patients with neutropenia. Intern Med J. 2011;41(1b):102\u20139.","journal-title":"Intern Med J"},{"issue":"11","key":"2524_CR12","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamainternmed.2021.5345","volume":"181","author":"N Buetti","year":"2021","unstructured":"Buetti N, Abbas M, Pittet D, de Kraker ME, Teixeira D, Chraiti M-N, et al. Comparison of routine replacement with clinically indicated replacement of peripheral intravenous catheters. JAMA Intern Med. 2021;181(11):1471\u20138.","journal-title":"JAMA Intern Med"},{"key":"2524_CR13","unstructured":"European Centre for Disease Prevention and Control. Surveillance of healthcare-associated infections and prevention indicators in European intensive care units Stockholm2017 [Available from: https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/HAI-Net-ICU-protocol-v2.2_0.pdf"},{"key":"2524_CR14","unstructured":"Centers for Disease Control and Prevention. CDC\/NHSN Master organism list 2023 [Available from: https:\/\/www.cdc.gov\/nhsn\/psc\/bsi\/index.html"},{"issue":"1","key":"2524_CR15","doi-asserted-by":"publisher","first-page":"e1918668","DOI":"10.1001\/jamanetworkopen.2019.18668","volume":"3","author":"CE Dandoy","year":"2020","unstructured":"Dandoy CE, Kim S, Chen M, Ahn KW, Ardura MI, Brown V, Incidence, et al. Risk factors, and outcomes of patients who develop mucosal barrier Injury\u2013Laboratory confirmed bloodstream infections in the first 100 days after allogeneic hematopoietic stem cell transplant. JAMA Netw Open. 2020;3(1):e1918668\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2524_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","volume":"21","author":"E Trecarichi","year":"2015","unstructured":"Trecarichi E, Pagano L, Candoni A, Pastore D, Cattaneo C, Fanci R, et al. Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey. Clin Microbiol Infect. 2015;21(4):337\u201343.","journal-title":"Clin Microbiol Infect"},{"key":"2524_CR17","first-page":"2371","volume":"20","author":"C-I Kang","year":"2012","unstructured":"Kang C-I, Song J-H, Chung DR, Peck KR, Yeom J-S, Son JS, et al. Bloodstream infections in adult patients with cancer: clinical features and pathogenic significance of Staphylococcus aureus bacteremia. Support Care Cancer. 2012;20:2371\u20138.","journal-title":"Support Care Cancer"},{"issue":"1","key":"2524_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.idh.2019.08.006","volume":"25","author":"AS Carvalho","year":"2020","unstructured":"Carvalho AS, Lagana D, Catford J, Shaw D, Bak N. Bloodstream infections in neutropenic patients with haematological malignancies. Infect Disease Health. 2020;25(1):22\u20139.","journal-title":"Infect Disease Health"},{"key":"2524_CR19","doi-asserted-by":"publisher","first-page":"e14152","DOI":"10.1111\/tid.14152","volume":"25","author":"N Singh","year":"2023","unstructured":"Singh N, Thursky K, Maron G, Wolf J. Fluoroquinolone prophylaxis in patients with neutropenia at high risk of serious infections: exploring pros and cons. Transpl Infect Disease. 2023;25:e14152.","journal-title":"Transpl Infect Disease"},{"issue":"4","key":"2524_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41409-023-01916-6","volume":"58","author":"M Yeshurun","year":"2023","unstructured":"Yeshurun M, Rozovski U, Shargian L, Pasvolsky O, van der Werf S, Tridello G, et al. Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT infectious disease working party survey. Bone Marrow Transplant. 2023;58(4):414\u201323.","journal-title":"Bone Marrow Transplant"},{"key":"2524_CR21","doi-asserted-by":"crossref","unstructured":"Vu D-L, Dayer J-A, Masouridi-Levrat S, Combescure C, Boely E, Khanna N, et al. Microbiologically documented infections after adult allogeneic hematopoietic cell transplantation: a 5-year analysis within the Swiss transplant cohort study. Transpl Infect Dis. 2020;22(4):e13289.","DOI":"10.1111\/tid.13289"},{"issue":"8","key":"2524_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1086\/502463","volume":"25","author":"F Daxboeck","year":"2004","unstructured":"Daxboeck F, Rabitsch W, Blacky A, Stadler M, Kyrle PA, Hirschl AM, et al. Influence of selective bowel decontamination on the organisms recovered during bacteremia in neutropenic patients. Infect Control Hosp Epidemiol. 2004;25(8):685\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"2524_CR23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ijantimicag.2017.08.008","volume":"50","author":"CM Wilk","year":"2017","unstructured":"Wilk CM, Weber I, Seidl K, Rachm\u00fchl C, Holzmann-B\u00fcrgel A, M\u00fcller AMS, et al. Impact of oral gut decontamination on Staphylococcus aureus colonisation in patients undergoing allogeneic Haematopoietic stem cell transplantation. Int J Antimicrob Agents. 2017;50(6):726\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2524_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40121-019-00257-6","volume":"8","author":"K Tatsuno","year":"2019","unstructured":"Tatsuno K, Ikeda M, Wakabayashi Y, Yanagimoto S, Okugawa S, Moriya K. Clinical features of bloodstream infections associated with peripheral versus central venous catheters. Infect Dis Therapy. 2019;8(3):343\u201352.","journal-title":"Infect Dis Therapy"},{"key":"2524_CR25","doi-asserted-by":"publisher","first-page":"107247","DOI":"10.1016\/j.ijid.2024.107247","volume":"148","author":"A MacPhail","year":"2024","unstructured":"MacPhail A, Chra\u00efti M-N, Zanella M-C, Hassoun-Kheir N, Catho G, Nguyen A, et al. Microbiology of catheter-associated bloodstream infection: differences according to catheter type. Int J Infect Dis. 2024;148:107247.","journal-title":"Int J Infect Dis"},{"issue":"10","key":"2524_CR26","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/myc.13148","volume":"63","author":"JD Jenks","year":"2020","unstructured":"Jenks JD, Cornely OA, Chen SCA, Thompson M III. Breakthrough invasive fungal infections: who is at risk? Mycoses. 2020;63(10):1021\u201332.","journal-title":"Mycoses"},{"key":"2524_CR27","doi-asserted-by":"crossref","unstructured":"Barnsteiner S, Baty F, Albrich WC, Babouee Flury B, Gasser M, Pl\u00fcss-Suard C et al. Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018. Euro Surveill. 2021;26(46).","DOI":"10.2807\/1560-7917.ES.2021.26.46.2001537"},{"key":"2524_CR28","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s10096-013-1819-7","volume":"32","author":"E Montassier","year":"2013","unstructured":"Montassier E, Batard E, Gastinne T, Potel G, de La Cocheti\u00e8re M. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Clin Microbiol Infect Dis. 2013;32:841\u201350.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"2524_CR29","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/S1473-3099(17)30485-1","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E, Sifakis F, Harbarth S, Schrijver R, van Mourik M, Voss A, et al. Surveillance for control of antimicrobial resistance. Lancet Infect Dis. 2018;18(3):e99\u2013106.","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"2524_CR30","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","volume":"65","author":"D Averbuch","year":"2017","unstructured":"Averbuch D, Tridello G, Hoek J, Mikulska M, Akan H, Ya\u0148ez San Segundo L, et al. Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group. Clin Infect Dis. 2017;65(11):1819\u201328.","journal-title":"Clin Infect Dis"},{"key":"2524_CR31","unstructured":"European Society for Medical Oncology (ESMO). Task Force. Medical Oncology Status in Europe Survey (MOSES) Phase II 2006 [Available from: https:\/\/www.esmo.org\/content\/download\/8359\/170041\/file\/2006-moses.pdf"},{"key":"2524_CR32","doi-asserted-by":"crossref","unstructured":"Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie TA, van de Wetering MD et al. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Reviews. 2012(1).","DOI":"10.1002\/14651858.CD004386.pub3"},{"issue":"8","key":"2524_CR33","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/S2352-3026(22)00166-1","volume":"9","author":"A Douglas","year":"2022","unstructured":"Douglas A, Thursky K, Spelman T, Szer J, Bajel A, Harrison S, et al. [18F] FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial. Lancet Haematol. 2022;9(8):e573\u201384.","journal-title":"Lancet Haematol"},{"key":"2524_CR34","doi-asserted-by":"crossref","unstructured":"Verlinden A, Jansens H, Goossens H, Anguille S, Berneman ZN, Schroyens WA et al. Safety and efficacy of antibiotic De-escalation and discontinuation in High-Risk hematological patients with febrile neutropenia: A Single-Center experience. Open Forum Infect Dis. 2021;9(3).","DOI":"10.1093\/ofid\/ofab624"},{"key":"2524_CR35","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00277-008-0687-1","volume":"88","author":"IF Chaberny","year":"2009","unstructured":"Chaberny IF, Ruseva E, Sohr D, Buchholz S, Ganser A, Mattner F, et al. Surveillance with successful reduction of central line-associated bloodstream infections among neutropenic patients with hematologic or oncologic malignancies. Ann Hematol. 2009;88:907\u201312.","journal-title":"Ann Hematol"},{"issue":"12","key":"2524_CR36","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/cid\/ciy825","volume":"68","author":"M Hakki","year":"2019","unstructured":"Hakki M, Humphries RM, Hemarajata P, Tallman GB, Shields RK, Mettus RT, et al. Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients. Clin Infect Dis. 2019;68(12):2045\u201352.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"2524_CR37","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/cid\/ciy363","volume":"67","author":"MJ Satlin","year":"2018","unstructured":"Satlin MJ, Chavda KD, Baker TM, Chen L, Shashkina E, Soave R, et al. Colonization with Levofloxacin-resistant Extended-spectrum \u03b2-Lactamase-producing Enterobacteriaceae and risk of bacteremia in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2018;67(11):1720\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02524-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:40:33Z","timestamp":1758721233000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["2524"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02524-w","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}